InSysBio to take part in ESMO Congress 2021

events
Conference
July 28, 2021

July 28, 2021

InSysBio announces its participation in ESMO (European Sosiety For Medical Oncology) Virtual Congress 2021 which is held on September 16-21. InSysBio team’s abstract was accepted:

  • #3143 “Selection of the optimal dose for ALX148, a CD47 blocker, using pharmacokinetic/pharmacodynamic modeling” by Elena Vasileva1,2, Oleg Demin Jr2

Affiliation: 1 Lomonosov Moscow State University, Moscow, Russia; 2InSysBio, Moscow, Russia

Abstract is going to be published on September 13, 2021, 00:05 CEST (Central European Summer Time)

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 120 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

July 2022
MoTuWeThFrSaSu
    
1
2
3
4
5
6
7
8
9
10
11
1. 11 Jul 2022 16:05 InSysBio team to publish the new article in Journal of Pharmacokinetics and Pharmacodynamics The new article "Application of different approaches to generate virtual patient populations for the quantitative systems pharmacology model of erythropoiesis" by Galina Kolesova, Alexander Stepanov, Galina Lebedeva and Oleg Demin has been recently published.
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
1. 27 Jul 2022 12:37 InSysBio to present posters at AAIC 2022 InSysBio announces its participation in AAIC 2022 (Online). Alzheimer’s Association International Conference is held July 31 – August 4, 2022 in San Diego, USA and Online. InSysBio Neurodegeneration Diseases team presents three posters within its frames
28
29
30
31
Upcoming Events
Tags
Latest News
11.07
InSysBio team to publish the new article in Journal of Pharmacokinetics and Pharmacodynamics
24.05
InSysBio to establish a new legal entity in Cyprus
25.04
InSysBio's ASCPT 2022 Micro-Theater Session on YouTube
20.01
InSysBio to release Immune Response Template v. 3.6.0
23.12
InSysBio to update CYTOCON DB and CYTOCON DB Open